Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988–2002

Vulto, Arnold G.; Louwman, Marieke W. J.; Rodrigus, P.; Coebergh, Jan Willem

doi:10.1016/j.radonc.2005.12.010

Cited by 28 publications

(18 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…À Second, the presence of comorbidity, particularly when combined with older age, is usually associated with the under-utilization of radiotherapy [22,23]. It should be recognized, however, that in specific indications such as muscle invasive bladder cancer, where surgery is indicated, radiotherapy could be the preferred option with increased utilization in the elderly with comorbidity [24].…”

Section: Discussionmentioning

confidence: 99%

The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis

Borràs

Lievens

Dunscombe

et al. 2015

Radiotherapy and Oncology

144

View full text Add to dashboard Cite

a b s t r a c tBackground and purpose: The absolute number of new cancer patients that will require at least one course of radiotherapy in each country of Europe was estimated. Material and methods: The incidence and relative frequency of cancer types from the year 2012 European Cancer Observatory estimates were used in combination with the population-based stage at diagnosis from five cancer registries. These data were applied to the decision trees of the evidence-based indications to calculate the Optimal Utilization Proportion (OUP) by tumour site. Results: In the minimum scenario, the OUP ranged from 47.0% in the Russian Federation to 53.2% in Belgium with no clear geographical pattern of the variability among countries. The impact of stage at diagnosis on the OUP by country was rather limited. Within the 24 countries where data on actual use of radiotherapy were available, a gap between optimal and actual use has been observed in most of the countries. Conclusions: The actual utilization of radiotherapy is significantly lower than the optimal use predicted from the evidence based estimates in the literature. This discrepancy poses a major challenge for policy makers when planning the resources at the national level to improve the provision in European countries.Ó 2015 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology xxx (2015) xxx-xxxThe estimated number of new cancer patients that require radiotherapy is a key parameter for planning the resources needed in a specific country in the framework of a cancer control programme. Most commonly, this calculation has been carried out using a specific proportion, typically the 'gold standard' of 50%, of the incident cases that would require radiotherapy at least http://dx

show abstract

Section: Discussionmentioning

confidence: 99%

The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis

Borràs

Lievens

Dunscombe

et al. 2015

Radiotherapy and Oncology

144

View full text Add to dashboard Cite

show abstract

“…The real rates of radiotherapy use vary greatly and are reported to be between 20% and 55% of cancers [2, 3, 6, 7, 10, 11]. Vulto et al [1], in a study of the population of the southern Netherlands conducted between 1988 and 2002, reported a rate of irradiation of 30-32%, analysing solely patients irradiated during the first 6 months after the oncological diagnosis, and showed annual increases of 3.3%. In Sweden, rates of 32% were calculated in 1992, which rose to 47% by 2001 [3].…”

Section: Irradiation Units Requiredmentioning

confidence: 99%

“…Another is the Canadian study conducted by the Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute (QCRI) [14][15][16]. The third is the Australian project conducted by the Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool, NSW [1]. Only the two most recent reviews provide a detailed quantification of the optimum rates of use of radiotherapy.…”

Section: Irradiation Units Requiredmentioning

confidence: 99%

“…The optimum rate for using radiotherapy based on the best available information was estimated by these authors following the Australian epidemiological pattern [1] in 52.3% of new cases of cancer registered (excluding nonmelanoma skin cancer and benign tumours), with a 95% confidence interval (CI) for safety of 51.7%-53.1% (multivariate analysis according to the Monte Carlo model). The application of these results to the pattern of cancers occurring in our country [20] enables an estimate to be made of the suitable rate of use of radiotherapy for each tumour type.…”

Section: Irradiation Units Requiredmentioning

confidence: 99%

“…Another type of difficulty must be taken into account when planning resources. Continuous evolution in the scientific evidence available marks the clinical indications for oncology and changes the requirements of irradiation in quantity and quality over short periods of time [1]. This uncertainty must be managed.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Radiation oncology: Future needs and equipment. Current situation in Spain

et al. 2008

View full text Add to dashboard Cite

Resumen La depresión unipolar es una de las patologías con mayor prevalencia en las sociedades occidentales. Los factores de riesgo son múltiples y muchos de ellos prevenibles. Sin embargo, en España no se toma demasiado en serio la planificación de la prevención primaria de la depresión. Concluimos que dicha si-tuación tiene diversas motivaciones políticas y aca-démicas. Las dos son superables, si se toma en serio la prevención de la depresión. Palabras clave: depresión unipolar, prevención pri-maria, prevención universal, programas de interven-ción preventiva. Abstract Unipolar depression is one of the most common illnesses in western society. There are multiple risk factors and many of them are preventable. However, planning of primary prevention of depression is not taken very seriously in Spain. We conclude that there are various political and academic reasons for this situation. They both can be overcome if we take prevention of depression more seriously.

show abstract

Provision and use of radiotherapy in Europe

2020

View full text Add to dashboard Cite

Radiation therapy is one of the core components of multidisciplinary cancer care. Although~50% of all European cancer patients have an indication for radiotherapy at least once in the course of their disease, more than one out of four cancer patients in Europe do not receive the radiotherapy they need. There are multiple reasons for this underutilisation, with limited availability of the necessary resourcesin terms of both trained personnel and equipmentbeing a major underlying cause of suboptimal access to radiotherapy. Moreover, large variations across European countries are observed, not only in available radiotherapy equipment and personnel per inhabitant or per cancer patient requiring radiotherapy, but also in workload. This variation is in part determined by the country's gross national income. Radiation therapy and technology are advancing quickly; hence, recommendations supporting resource planning and investment should reflect this dynamic environment and account for evolving treatment complexity and fractionation schedules. The forecasted increase in cancer incidence, the rapid introduction of innovative cancer treatments and the more active involvement of patients in the healthcare discussion are all factors that should be taken under consideration. In this continuously changing oncology landscape, reliable data on the actual provision and use of radiotherapy, the optimal evidence-based demand and the future needs are crucial to inform cancer care planning and address and overcome the current inequalities in access to radiotherapy in Europe.

show abstract

Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988–2002

Cited by 28 publications

References 47 publications

The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis

The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis

Radiation oncology: Future needs and equipment. Current situation in Spain

Provision and use of radiotherapy in Europe

Contact Info

Product

Resources

About